Erleada patent expiration?

When Does the Erleada Patent Expire?

Erleada, also known as apalutamide, is an oral medication used for the treatment of prostate cancer. The patent for Erleada was granted to Janssen Biotech, Inc., and its expiration has been a topic of interest for many in the pharmaceutical industry.

According to DrugPatentWatch.com [1], the patent for Erleada's active ingredient expires in 2032 (US Patent Expiration Date: [March 23, 2032]). However, it's essential to note that this date may not necessarily impact the availability of the drug on the market. Pharmaceutical companies can often file for approval of generic versions of a medication before the patent expires, and these versions may become available shortly after the patent expires.

What Happens When the Patent Expires?

When the patent for Erleada expires, other companies can start manufacturing and marketing generic versions of the medication. These generic alternatives may be cheaper than the brand-name version, which could lead to increased competition in the market. However, it's worth noting that the manufacturer of Erleada, Janssen Biotech, may still have some market exclusivity under certain circumstances.

Can Biosimilars Enter Before Patent Expiration?

Biosimilars are biologic medications that are designed to be highly similar to an existing biologic medication, such as Erleada. According to the Biosimilars Action Team, biosimilars are subject to a separate approval process from generic medications [2]. In the United States, biosimilars can be approved before the patent expires for a biologic medication, but the manufacturer of the biologic must offer a notice of commercial marketing and a 180-day market exclusivity period to the FDA.

When Does Exclusivity Expire?

The exclusive marketing rights for Erleada currently expire on October 1, 2034, however, this date can be extended if a 5-year pediatric exclusivity is granted by the FDA. It is always a good idea to verify the dates with the FDA.

Patent Expiration Date vs. Exclusivity Expiration Date

It's essential to note that the patent expiration date and exclusivity expiration date are two separate concepts. The patent expiration date signals that the exclusive rights to a medication's active ingredient have expired, while the exclusivity expiration date marks the end of the exclusive marketing rights for a medication.

Sources:

[1] DrugPatentWatch.com - Apalutamide Patent Expiration Date
[2] Biosimilar Action Team - Biosimilars Overview